DataTern, Inc. Signs Three IP License Agreements worth $1.65m

New York, 5 May 2009

DataTern, Inc., today announces that it has signed non-exclusive intellectual property license agreements with three leading international corporations for a total of $1.65 million. DataTern has signed seven licenses since it commenced licensing of this product in June 2008, generating total revenues of approximately $7 million. DataTern has now licensed its intellectual property into the financial, credit card, retail, leisure, healthcare, and software industries.

Joseph Flicek, DataTern’s Chief Executive Officer, said, “We have made rapid progress in a relatively short period of time, demonstrating the value that can be extracted from our intellectual property portfolio. We believe there are a large number of potential licensees in a broad spectrum of industries for our IP. Currently, we are in active discussions with six other major corporations and we continue to add to this list.”

DataTern, Inc., wholly owned by Amphion Innovations plc (LSE: AMP), was established in order to commercialize selected intellectual property opportunities in partnership with Amphion’s Partner Companies.

Richard Morgan, Chief Executive Officer of Amphion, said, “Today’s announcement demonstrates the value that Amphion can generate for its shareholders through monetising our intellectual property. We continue to add further patents and software though the activities of DataTern and our Partner Companies and we look forward to signing further license agreements.”

---

For further information please contact:

DataTern, Inc.
Joseph Flicek
+1 212.210.6282

---

 

About DataTern, Inc.

DataTern owns and develops critical technology that provides next generation software solutions for our customers. DataTern’s patented product offering include ObjectSpark® Technologies, which allow customers to develop their own customized data services layers, making the company’s offerings valuable to most industries, including automotive, banking, chemical, communications, financial, government, healthcare, insurance, pharmaceutical, trading, and many others. Non-exclusive licenses for DataTern’s technologies and patents are available on reasonable and non-discriminatory terms. For licensing terms, please contact info@datatern.com.

On the web: www.datatern.com

 

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.   Amphion has significant shareholding in 10 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

On the web: www.amphionplc.com